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Abstract
Context: Pubertal timing is under strong genetic control and its early onset associates with several adverse health outcomes
in adulthood, including obesity, type 2 diabetes and cardiovascular disease. Recent data indicate strong association
between pubertal timing and genetic variants near LIN28B, but it is currently unknown whether the gene contributes to the
association between puberty and adult disease.
Objective: To elucidate the putative genetic link between early puberty and adult disease risk, we examined the association
of two genetic variants near LIN28B with adult body size and metabolic profiles in randomly ascertained adult Finnish males
and females.
Methods: Two single nucleotide polymorphisms (SNPs), rs7759938, the lead SNP previously associated with pubertal timing
and height, and rs314279, previously also associated with menarcheal age but only partially correlated with rs7759938
(r2 = 0.30), were genotyped in 26,636 study subjects participating in the Finnish population survey FINRISK. Marker
associations with adult height, weight, body mass index (BMI), hip and waist circumference, blood glucose, serum insulin
and lipid/lipoprotein levels were determined by linear regression analyses.
Results: Both rs7759938 and rs314279 associated with adult height in both sexes (p = 261026 and p= 0.001). Furthermore,
rs314279 associated with increased weight in females (p = 0.001). Conditioned analyses including both SNPs in the
regression model verified that rs314279 independently associates with adult female weight, BMI and hip circumference
(p,0.005). Neither SNP associated with glucose, lipid, or lipoprotein levels.
Conclusion: Genetic variants near the puberty-associated gene LIN28B associate with adult weight and body shape in
females, suggesting that the gene may tag molecular pathways influencing adult adiposity-related traits.
Citation: Leinonen JT, Surakka I, Havulinna AS, Kettunen J, Luoto R, et al. (2012) Association of LIN28B with Adult Adiposity-Related Traits in Females. PLoS
ONE 7(11): e48785. doi:10.1371/journal.pone.0048785
Editor: Shengxu Li, Tulane School of Public Health and Tropical Medicine, United States of America
Received June 5, 2012; Accepted October 1, 2012; Published November 13, 2012
Copyright:  2012 Leinonen et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This study has been financially supported by the Academy of Finland (grant no. 129287, 134839, 120315 and 218029; http://www.aka.fi/en-GB/A/). The
funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: elisabeth.widen@helsinki.fi
Introduction
A wealth of epidemiological data show that the overall risk for
many adult-onset multi-factorial disorders may correlate with
distinct growth patterns during early development [1]. Puberty
represents an example of such a developmental event. The timing
of puberty is strongly regulated by genes and early timing has been
associated with an increased risk for various adverse health
outcomes, including obesity, type 2 diabetes, cardiovascular
disease and hormone dependent cancers [2–5]. Multiple mecha-
nisms likely account for these correlations, but evidence exists for
shared genetic pathways influencing both puberty and adult health
[6].
Although the genetic framework influencing pubertal timing in
the general population remains poorly understood, recent
genome-wide association (GWA) studies have initiated the
identification of puberty-associated genes. The effect of LIN28B
on pubertal timing has been particularly well established [2,7–11].
Whether LIN28B, encoding for a protein inhibiting let-7 micro-
RNA biosynthesis, contributes to the risk for puberty-associated
disease remains unclear. Even though variants near the gene have
been associated with adult height and 2D:4D digit-length ratio in
humans, it has not been implicated in the recent large GWA
studies of obesity-related traits or Type 2 diabetes [12–15].
Nonetheless, studies in mice suggest that the LIN28-genes can
influence energy homeostasis and glucose metabolism [16,17].
Additionally, a longitudinal study of 1,242 men and 1,209 women
implies that puberty-associated variants at LIN28B may associate
with a transient BMI-increase from adolescence to mid-adulthood
[18]. Thus, it is possible that the effects of LIN28B on adult energy
metabolism are subtle and limited to specific periods of adolescent
and adult life. In fact, epidemiological studies suggest that the
genetic influences on body composition in general may become
less prominent with increasing age [19].
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To evaluate the impact of LIN28B on adult adiposity-related
and metabolic traits we conducted a genetic association study in a
large, homogenous Finnish study population encompassing 26,636
adult subjects aged 25 to 74 years. Our specific aim was to study
two partially correlated SNPs upstream of LIN28B, rs7759938 and
rs314279, and assess their association with adult body size, lipids
and glucose metabolism 1) in the study population as a whole, and
2) in specific age groups of the population. rs7759938 has
previously been robustly linked with pubertal growth and
maturation [2,7]. Association with menarcheal age (age at
menarche, AAM) has also been reported for rs314279 [2]. This
marker is only partially correlated with rs7759938 (pair-wise
r2 = 0.30). However, many of the cohorts participating in the large
meta-analysis study of AAM did not have data for this marker.
Also, conditioned analyses interrogating the presence of two
independent effects influencing pubertal timing were not carried
out [2]. Even though the presence of two independent effects
influencing AAM has not been confirmed, we still decided to
include rs314279 in our analyses to gain a broad coverage of all
potentially associated variation. The large sample size in
combination with extensive phenotypic characterization makes
the current study particularly well suited for detecting pleiotropic
effects. Moreover, in a homogenous population such as the Finnish
population, a limited number of mutations may underlie both
Mendelian and complex traits, thereby improving the power to
detect single associated variants.
Materials and Methods
Ethics Statement
All participants gave their written informed consent, and the
study protocols were approved by the institutional ethical review
boards of the National Institute for Health and Welfare, and the
Helsinki University Hospital, Helsinki, Finland.
Study Subjects
The study subjects were participants of the Finnish National
FINRISK study, which is a series of Finnish population-based
surveys, performed since 1972 at five-year intervals to characterize
risk factors for non-communicable disease [20]. The individual
FINRISK cohorts, stratified to contain at least 200 subjects of each
sex in 10-year age groups (range 25 to 74 years), represent six
distinct geographical regions in Finland. Our study included 5,616
study subjects from FINRISK 1992, 6,869 from FINRISK 1997,
8,257 from FINRISK 2002 and 5,908 study subjects from
FINRISK 2007 with DNA samples available.
Data Collection
The study participants were invited to a health inspection
during which height, weight, waist and hip circumferences were
measured by trained nurses using standardized procedures [20].
Height and weight were self-reported only by 94 and 92 subjects,
respectively. The participants were instructed to fast for four hours
and blood samples were drawn for DNA extraction and the
determination of blood lipid, and lipoprotein concentrations.
Blood glucose and insulin were measured from participants of
FINRISK 2007 during a separate 75 g oral glucose tolerance test.
Descriptive cohort statistics are shown in Table S1.
The study subjects were genotyped for rs7759938 and rs314279
using a Sequenom MassARRAY genotyping platform (Sequenom
Inc., San Diego, USA). Individual genotypes were automatically
called with Typer 4.0 Analyzer software, whereas the genotype
clusters were manually checked. The genotyping success rate was
.98% for both markers, and the minor allele frequencies (MAF)
in the study sample were 0.32 for rs7759938 and 0.13 for
rs314279. The observed pair-wise r2 between the markers was
0.30. The genotype frequencies were in Hardy-Weinberg equilib-
rium at both loci in all participating cohorts.
Statistical Analysis
Linear regression analyses were carried out using PLINK [21].
Sex-stratified single marker analyses were run separately for each
participating cohort, assuming an additive genetic model and
adjusting for age. Because the two tested markers are only partially
correlated, (r2 = 0.3, and D’ = 1), indicating that they are separated
by a mutational event and not by recombination, we additionally
evaluated the independent effect at each locus by separate analyses
including both SNPs in the regression model. To measure the
collinearity of the two SNPs in the regression analyses, the
variants’ variance inflation factor (VIF) was computed for each
anthropometric trait with R (http://www.r-project.org/). The
results of the individual cohorts were meta-analysed by MetABEL
(http://www.genabel.org/packages/MetABEL) in R 2.12.2. Ad-
ditionally, SNP by age and SNP by sex interactions were assessed
for both markers separately by multiple linear regression analysis.
Although multiple tests were carried out in this study, the exact
number of independent tests is not easily determined since the
tested response variables are partially correlated. To maintain
conservative interpretation of the analysis results, we set the
significance threshold to p,0.005, corresponding to Bonferroni-
correction accounting for ten independent tests.
Results
We first assessed the effect of rs7759938 and rs314279 on adult
body size (Table 1). As expected, the puberty-associated marker
rs7759938 was significantly associated with adult height in both
sexes (p = 261026). However, it did not associate with weight,
body mass index, or waist and hip circumference. Also rs314279
showed association with adult height (p = 0.001). Moreover, the
height-increasing allele C at rs314279 significantly associated with
increased weight (p = 0.001), and hip circumference (p = 0.003),
mostly due to associations in females (Table 1). Even though the
associations were generally stronger in females, subsequent sex-
interaction analyses did not reveal any statistically significant
evidence for sex-specific effects (Table S2).
To assess the potential independent effects at each marker, we
repeated the regression analyses including both SNPs in the
regression model (Table 1). The data confirmed that the two
markers associate with different phenotypes. Whereas rs7759938
completely accounted for the association with height, the observed
effects on female body size were attributed to rs314279. More
specifically, by including both SNPs in the analysis of height the
association with rs7759938 changed only a little (p = 0.0002),
whereas the effect of rs314279 was completely abolished. Also, the
conditioned analyses indicated an association between the height-
increasing allele at rs7759938 and increased WHR in males. In
contrast, including both SNPs in the regression model resulted in
unchanged or further enhanced association between rs314279 and
weight, BMI and hip circumference in females (p,0.005) (Table 1).
Because multiple regression analyses of correlated predictor
variables may give rise to erratic individual coefficient estimates,
we tested the validity of the conditioned model by computing VIFs
for the two SNPs in the analyses for each anthropometric trait
(Table S3). The analyses revealed only limited levels of collinearity
as evidenced by VIF ,5, thereby supporting the validity of the
conditioned model.
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We next wanted to evaluate whether the associations between
the LIN28B markers and body size are influenced by age. Plotting
height, weight and BMI against calendar age showed strong
correlation between these measures and age (Figure S1). None-
theless, multiple regression analysis failed to reveal any evidence
for significant SNP by age interaction (Table S4). Re-analysis of
the data by specific age bins, covering 10-year age ranges spanning
from 25 to 74 years, confirmed that the association patterns were
mostly similar in all age groups (Table S5).
Finally, to test whether either of the SNPs near LIN28B
associates with adult metabolic profiles, linear regression analyses
of serum lipid, lipoprotein and insulin and plasma glucose
measures were performed (Table 2). On average, roughly 17,500
study subjects (66%) had lipid measurements available for
analyses, whereas glucose and insulin data from an oral glucose
tolerance test was available for some 4,000 subjects (15%). We
observed no significant associations with lipid or lipoprotein levels.
However, rs314279 associated with fasting insulin levels in males
(p = 0.003). As this was the only observed association with
metabolic outcomes, and because insulin data was available only
for a limited number of the study subjects, follow-up studies are
needed to verify the finding.
Discussion
In recent years, the evolutionarily conserved gene LIN28B has
been convincingly associated with both timing of puberty and
growth in height in humans [2,7–12]. Highlighting its pleiotropic
effects, the locus has also been associated with finger-length ratio
[13]. Mice over-expressing the homologous gene, LIN28A,
Table 1. Association of genetic variants rs7759938 (upper panel) and rs314279 (lower panel) with adult anthropometric traits.
rs7759938 ALL MALES FEMALES
RESPONSE
VARIABLE
(MODEL) N (M,F) BETA (SE) P BETA (SE) P BETA (SE) P
Height (A) 26379 (12258, 14121) 0.042 (0.009) 261026 0.032 (0.013) 0.01 0.051 (0.012) 0.00002
Height (B) 26237 (12187, 14050) 0.038 (0.010) 0.0002 0.029 (0.015) 0.06 0.046 (0.014) 0.001
Weight (A) 26377 (12257, 14120) 0.015 (0.009) 0.09 0.016 (0.014) 0.25 0.015 (0.013) 0.22
Weight (B) 26235 (12186, 14049) 20.001 (0.011) 0.93 0.009 (0.016) 0.56 20.010 (0.015) 0.52
BMI (A) 26375 (12256, 14119) 20.002 (0.009) 0.78 20.001 (0.013) 0.97 20.004 (0.012) 0.73
BMI (B) 26233 (12185, 14048) 20.018 (0.010) 0.10 20.008 (0.016) 0.63 20.026 (0.015) 0.07
Waist (A) 26314 (12291, 14023) 0.013 (0.009) 0.13 0.023 (0.013) 0.08 0.005 (0.012) 0.67
Waist (B) 26173 (12220, 13953) 0.007 (0.010) 0.52 0.026 (0.015) 0.09 20.010 (0.014) 0.48
Hip (A) 26313 (12289, 14024) 0.009 (0.009) 0.33 0.010 (0.013) 0.45 0.007 (0.012) 0.54
Hip (B) 26172 (12218, 13954) 20.008 (0.010) 0.46 0.001 (0.016) 0.96 20.015 (0.014) 0.29
WHR (A) 26307 (12286, 14021) 0.013 (0.009) 0.14 0.026 (0.012) 0.04 0.000 (0.012) 0.98
WHR (B) 26166 (12215, 13951) 0.021 (0.010) 0.05 0.043 (0.015) 0.004 20.000 (0.014) 0.98




N (M,F) BETA (SE) P BETA (SE) P BETA (SE) P
Height (A) 26288 (12213, 14075) 0.039 (0.012) 0.001 0.030 (0.018) 0.09 0.047 (0.017) 0.005
Height (B) 26237 (12187, 14050) 0.010 (0.015) 0.51 0.008 (0.022) 0.70 0.011 (0.020) 0.60
Weight (A) 26286 (12212, 14074) 0.042 (0.013) 0.001 0.025 (0.019) 0.20 0.057 (0.018) 0.001
Weight (B) 26235 (12186, 14049) 0.043 (0.016) 0.006 0.020 (0.023) 0.39 0.063 (0.021) 0.003
BMI (A) 26284 (12211, 14073) 0.026 (0.013) 0.04 0.011 (0.019) 0.55 0.039 (0.017) 0.02
BMI (B) 26233 (12185, 14048) 0.040 (0.015) 0.008 0.017 (0.022) 0.44 0.059 (0.020) 0.004
Waist (A) 26224 (12246, 13978) 0.022 (0.012) 0.08 0.011 (0.018) 0.55 0.031 (0.017) 0.07
Waist (B) 26173 (12220, 13953) 0.017 (0.014) 0.24 20.007 (0.021) 0.76 0.038 (0.020) 0.06
Hip (A) 26223 (12244, 13979) 0.038 (0.012) 0.003 0.026 (0.019) 0.17 0.048 (0.017) 0.006
Hip (B) 26172 (12218, 13954) 0.045 (0.015) 0.003 0.028 (0.023) 0.21 0.060 (0.021) 0.004
WHR (A) 26217 (12241, 13976) 20.003 (0.012) 0.80 20.009 (0.017) 0.59 0.003 (0.017) 0.86
WHR (B) 26166 (12215, 13951) 20.019 (0.014) 0.18 20.042 (0.021) 0.04 0.003 (0.021) 0.89
All phenotypes were standardized prior to analyses. Two regression models were used: Model A including age as a covariate, Model B including both the alternative SNP
and age as covariates. The effect allele for both rs7759938 and rs314279 is C. BMI = body mass index, WHR = waist to hip ratio.
doi:10.1371/journal.pone.0048785.t001
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recapitulate the same phenotypes as observed in human GWA-
studies, including increased growth in length and delayed onset of
puberty [16]. Additionally, overexpression of LIN28B in muscle
tissue renders mice under high fat diet resistant to weight gain
through increased peripheral glucose uptake and insulin sensitivity
[17]. The extent to which LIN28B may impact on adiposity and
energy metabolism in humans is currently unknown. This study,
including 26,636 adult study subjects from the homogenous
population of Finland, identified evidence supporting that genetic
Table 2. Association of genetic variants rs7759938 (upper panel) and rs314279 (lower panel) with adult metabolic profiles.
rs7759938 ALL MALES FEMALES
RESPONSE
VARIABLE
(MODEL) N (M,F) BETA (SE) P BETA (SE) P BETA (SE) P
Cholesterol (A) 17622 (7974, 9648) 20.020 (0.011) 0.06 20.027 (0.017) 0.11 20.016 (0.014) 0.26
Cholesterol (B) 17530 (7930, 9600) 20.017 (0.013) 0.19 20.014 (0.020) 0.47 20.019 (0.017) 0.26
HDL (A) 17617 (7973, 9644) 20.001 (0.011) 0.94 20.017 (0.017) 0.31 0.012 (0.015) 0.41
HDL (B) 17525 (7929, 9596) 20.007 (0.014) 0.61 20.032 (0.020) 0.11 0.014 (0.018) 0.44
Triglycerides# (A) 17624 (7975, 9649) 20.008 (0.011) 0.48 0.003 (0.017) 0.85 20.017 (0.015) 0.26
Triglycerides# (B) 17532 (7931, 9601) 20.009 (0.013) 0.49 0.004 (0.020) 0.86 20.019 (0.018) 0.28
APOA1 (A) 14302 (6428, 7874) 20.001 (0.012) 0.91 20.010 (0.019) 0.59 0.005 (0.016) 0.76
APOA1 (B) 14227 (6391, 7836) 20.009 (0.014) 0.54 20.028 (0.022) 0.22 0.004 (0.018) 0.82
APOB (A) 14443 (6496, 7947) 20.022 (0.012) 0.07 20.032 (0.018) 0.08 20.014 (0.016) 0.38
APOB (B) 14368 (6459, 7909) 20.010 (0.014) 0.49 20.013 (0.022) 0.56 20.008 (0.019) 0.68
FP Glucose (A) 4123 (1840, 2283) 0.007 (0.023) 0.74 0.015 (0.035) 0.67 0.002 (0.030) 0.95
FP Glucose (B) 4111 (1833, 2278) 20.007 (0.027) 0.79 0.018 (0.040) 0.65 20.027 (0.035) 0.45
2H Glucose (A) 4042 (1828, 2214) 20.030 (0.023) 0.19 20.001 (0.046) 0.99 20.049 (0.036) 0.18
2H Glucose (B) 4032 (1822, 2210) 20.017 (0.027) 0.43 0.011 (0.030) 0.72 20.011 (0.027) 0.68
FS Insulin# (A) 4099 (1865, 2234) 20.013 (0.024) 0.58 0.002 (0.035) 0.96 20.025 (0.032) 0.44
FS Insulin# (B) 4088 (1859, 2229) 20.001 (0.028) 0.98 0.076 (0.041) 0.06 20.066 (0.038) 0.08




N (M,F) BETA (SE) P BETA (SE) P BETA (SE) P
Cholesterol (A) 17564 (7945, 9619) 20.022 (0.015) 0.16 20.041 (0.023) 0.08 20.008 (0.020) 0.71
Cholesterol (B) 17530 (7930, 9600) 20.009 (0.018) 0.63 20.031 (0.028) 0.28 0.007 (0.024) 0.77
HDL (A) 17559 (7944, 9615) 0.010 (0.016) 0.51 0.014 (0.024) 0.55 0.007 (0.022) 0.74
HDL (B) 17525 (7929, 9596) 0.016 (0.019) 0.42 0.040 (0.029) 0.17 20.005 (0.026) 0.85
Triglycerides# (A) 17566 (7946, 9620) 20.004 (0.016) 0.80 0.000 (0.023) 0.99 20.007 (0.021) 0.73
Triglycerides# (B) 17532 (7931, 9601) 0.004 (0.019) 0.85 20.003 (0.028) 0.92 0.009 (0.025) 0.73
APOA1 (A) 14258 (6403, 7874) 0.012 (0.017) 0.47 0.023 (0.027) 0.40 0.005 (0.023) 0.82
APOA1 (B) 14227 (6391, 7836) 0.019 (0.020) 0.36 0.044 (0.032) 0.17 0.001 (0.027) 0.98
APOB (A) 14400 (6472, 7928) 20.038 (0.017) 0.02 20.060 (0.026) 0.02 20.021 (0.023) 0.34
APOB (B) 14368 (6459, 7909) 20.030 (0.020) 0.14 20.052 (0.031) 0.09 20.013 (0.027) 0.63
FP Glucose (A) 4121 (1837, 2284) 0.036 (0.032) 0.27 0.003 (0.050) 0.95 0.059 (0.042) 0.16
FP Glucose (B) 4111 (1833, 2278) 0.041 (0.029) 0.16 20.010 (0.058) 0.87 0.087 (0.050) 0.08
2H Glucose (A) 4042 (1826, 2216) 20.044 (0.032) 0.17 20.051 (0.048) 0.29 20.038 (0.042) 0.37
2H Glucose (B) 4032 (1822, 2210) 20.028 (0.037) 0.56 20.065 (0.056) 0.25 20.002 (0.050) 0.97
FS Insulin# (A) 4098 (1863, 2235) 20.031 (0.034) 0.36 20.152 (0.051) 0.003 0.064 (0.045) 0.15
FS Insulin# (B) 4088 (1859, 2229) 20.029 (0.040) 0.46 20.211 (0.059) 0.0004 0.118 (0.053) 0.03
All phenotypes were standardized prior to analyses. Two regression models were used: Model A including age as a covariate, and Model B including both the alternative
SNP and age as covariates. Subjects using lipid lowering drugs or with lipid levels +/25 standard deviations (SD) from the mean were excluded from the lipid/
lipoprotein analysis. Only subjects with normal glucose tolerance not receiving treatment for diabetes were included in the regression analyses of glucose and serum
insulin. The effect allele for both rs7759938 and rs314279 is C. ApoA1= Apolipoprotein A1, ApoB = Apolipoprotein B, FP = Fasting plasma. FS = Fasting serum, 2H
glucose = Plasma glucose concentrations at 2 h after a 75 g oral glucose load. Participants of the oral glucose test were instructed to fast for 10 hours. # The variable
was logarithm-transformed prior to the analysis.
doi:10.1371/journal.pone.0048785.t002
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variation near LIN28B impacts body weight, BMI and hip
circumference predominantly in females.
In the current study, we chose to genotype two genetic markers
located upstream of LIN28B, rs7759938 and rs314279. The
former has been robustly associated with pubertal timing and adult
height. The latter, here associating with female body size and male
insulin levels, appears to be less well studied. The pair-wise
correlation of rs314279 with rs7759938 (the lead SNP associating
with AAM) is only 0.30, and a large meta-analysis including
87,802 women reported evidence also for association between
rs314279 and AAM. The finding may indicate the presence of two
independent effects at the LIN28B region influencing the trait.
Nonetheless, this has not been confirmed. Many of the cohorts
participating in the meta-analysis study of AAM were lacking data
for the marker rs314279, and conditioned analyses interrogating
the independent effect of that marker were not carried out [2]. It is
possible that rs314279 is poorly covered by large GWA studies in
general and that limited data availability might explain why
previous GWA studies of BMI, in contrast to our study, have not
detected association between BMI and this particular marker [14].
More importantly, in our study the impact of rs314279 on body
size appeared stronger when adjusting for the partially correlated
rs7759938, but in previous GWA-studies of BMI this model has
not been assessed in detail. Finally, whereas our study targets a
single, homogenous population, the GWA studies are mostly based
on meta-analysis of multiple distinct study cohorts. Therefore, the
discrepancy in results might in part originate from a population
specific effect, although the accumulated data from association
studies of common genetic variants show little evidence for
variation in phenotype response between different populations of
European descent. Nonetheless, even if our study sample is large,
we do acknowledge that further replication studies are needed to
verify the findings.
So far only one other study has suggested that genetic variants
near LIN28B may affect adult BMI [18]. In that study the effect of
rs314276 on BMI was evaluated, and the authors found evidence
for an age-dependent interaction between the SNP and BMI, in
females. Even though rs314276 is completely correlated with one
of the markers in the current study, rs7759938, we could not
replicate the previous finding. In our study we did not find any
evidence for genotype by age interaction at any of the tested
marker loci. Of note, the two studies differ by study design, the
former being a longitudinal study of a birth cohort and our study
representing a cross-sectional study including individuals born
between 1923 and 1982. Thus it is possible that varying
environmental influences may have prevented detection of an
existing age interaction in our study. The disparate results could
also be due to differences in the LD-structure between the study
populations. Finally, given the power needed to robustly show
gene-environment interactions, the results reported in the previous
study may represent a false positive effect. Thus, further targeted
replication studies are required to elucidate the detailed contribu-
tion of LIN28B to human body shape and adiposity.
In conclusion, this study shows that genetic variants near
LIN28B in addition to influencing height growth also associate
with female body shape. These data support the accumulating
evidence linking LIN28B-mediated pathways with adult adiposity-
related traits.
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